Senior Staff Scientist: The Shah Lab and Department of Pediatrics at MSKCC is seeking a highly motivated Senior Staff Scientist with a strong background in cancer genomics. This role is part of an interdisciplinary team dedicated to understanding pediatric cancers and improving treatment options through genomic discoveries.
Designation
Senior Staff Scientist
Research Area
Pediatric Cancer Genomics, Computational Biology, Molecular Biology
| Field | Details |
|---|---|
| Location | Macklowe Building, 323 East 61st Street, New York, NY 10065 |
| Salary Range | $120,000 – $160,000 |
| Schedule | Flexible in-person (average of 4 days a week onsite) |
| Visa Sponsorship | Available for eligible candidates |
Eligibility/Qualification
- PhD in Bioinformatics, Computational Biology, or Computer Science with an emphasis on molecular biology applications.
- Proficiency with data analysis in Python or R.
- Experience with Linux and command line usage.
- Familiarity with Git for collaborative coding.
- Experience with high-throughput sequencing data and single-cell genomics.
Job Description
As a Senior Staff Scientist, you will:
- Collaborate with physician-scientists to analyze genomic data from pediatric cancer patients.
- Engage with bulk and single-cell sequencing datasets to explore clinically relevant questions.
- Develop computational methods tailored for cutting-edge sequencing technologies (single-cell and long-read).
- Publish high-impact research articles and present findings at conferences.
- Stay updated on advances in computational biology to inform your analyses.
How to Apply
Interested candidates should email mcphera1@mskcc.org with the following:
- A link to one or two representative papers, including a brief description of your specific contributions.
- Examples of your code on GitHub to demonstrate your computational skills.
- Your CV attached to the email.
Last Date to Apply
Applications will be accepted until the position is filled. Early applications are encouraged.
Join us in advancing the fight against pediatric cancer through innovative research!
